Speakers to Present on New Research on Medical Uses for Psychedelic Drugs, Drug Policy Reform Advocacy, and More
DPA’s Stefanie Jones to Present on “Psychedelics, Partying, and Policy”
Horizons focuses on state-of-the-art research into the wide range of applications for psychedelics, providing an invaluable forum for experts and interested others to share ideas and insights, and to rethink the future of these unique substances in science, medicine, culture, and history.
This year, researchers, scholars, and practitioners from the United States, England and Brazil will present new research and insights in neuroscience, end-of-life anxiety, PTSD, substance abuse/addiction, recreational use, public policy, activism, and more.
There are currently significant clinical studies being carried out assessing the different medical uses psilocybin can offer. Researchers at the New York University School of Medicine have been examining the potential of the psychoactive agent to address anxiety and depression associated with cancer through changes in attitudes, awareness and spiritual perceptions of quality of life. Researchers at Johns Hopkins School of Medicine carried out a similar study and have been also looking at spiritual/mystical experiences induced by psilocybin for people interested in smoking cessation. Researchers from both schools will be sharing insights and results from their respective studies.
This year’s presentations include:
“The Voices of the NYU Psilocybin Cancer Anxiety Project”
From left, Jeffrey Guss, Gabrielle Agin-Liebes, Stephen Ross, and Anthony Bossis of the NYU Psilocybin Cancer Anxiety Project
[NYU Alumni Magazine]
Jeffrey Guss, M.D., Clinical Assistant Professor of Psychiatry and Child and Adolescent Psychiatry at New York University School of Medicine
Patrick Murphy, B.F.A., Film & Television, New York University Tisch School of the Arts, Casa Vera Productions
“Current Work with Psilocybin in the Treatment of Alcoholism”
Michael P. Bogenschutz, M.D., Professor of Psychiatry, NYU School of Medicine
“Psychedelic Brain Imaging and Depression”
Dr. Robin Carhart-Harris
[Vimeo]
“Ayahuasca, Awareness and Depression”
Draulio Barros de Araujo, Ph.D., Professor of Neuroimaging, Brain Institute, Natal, Brazil
“Psilocybin, Meditation, Mystical Experiences, and the Brain”
Frederick Barrett, Ph.D., Faculty Member in Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine
Daniel Pinchbeck, left, and Rick Doblin will be presenting at the conference
[Horizons: Perspectives on Psychedelics 2015]
Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)
“Psychedelics, Partying, and Policy”
Stefanie Jones, Nightlife Community Engagement Manager, Drug Policy Alliance
“Psychedelics and Death: A Brief Introduction”
Dr. Neil Goldsmith
[YouTube]
“Psychedelics and Deep Ecology”
Daniel Pinchbeck, Psychotherapist and author, Author and Co-founder of evolver.net and Reality Sandwich
For a full list of speakers, partners, registration details, and additional information on the conference visit http://horizonsnyc.org.
A similar conference was held earlier in October this year in Victoria BC featuring Dr Gabor Mate, psychiatrists Ingrid Pacey and Donna Dryer, Richard Yensen and more excellent presenters. Video of the entire Forum is available at http://www.psychedelicpsychotherapy.ca.